Statistical Analysis Code: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL OF TAMOXIFEN COMBINED WITH AMPHOTERICIN B AND FLUCONAZOLE FOR CRYPTOCOCCAL MENINGITIS

Dataset

Documentation:: These code were created in 2020 and 2021 to analyse the clinical trial: AN OPEN LABEL RANDOMIZED CONTROLLED TRIAL OF TAMOXIFEN COMBINED WITH AMPHOTERICIN B AND FLUCONAZOLE FOR CRYPTOCOCCAL MENINGITIS. The deposit consists of R and SAS code to analyse the trial dataset. The programmes R and SAS are needed to run the code.

Files:: 1_28CN_analysis_finalized.Rmd

(Version of record, 63.4KB, Terms of use)

miscRfunctions28cn.r

(Version of record, 39.9KB, Terms of use)

1a_28CN_ImportTablesFromAccess.sas

(Version of record, 5.7KB, Terms of use)

1b_28CN_CreateVAD_AE.sas

(Version of record, 11.1KB, Terms of use)

1d_28CN_CreateVADs.sas

(Version of record, 71.6KB, Terms of use)

1e_28CN_exportVAD.sas

(Version of record, 2.0KB, Terms of use)

Readme.docx

(Version of record, 11.4KB, Terms of use)

Grant:: Intermediate Fellowship to JND grant number WT097147MA; Wellcome Trust Asia Programme Vietnam Core Grant 106680

Publisher:: University of Oxford
Publication date:: 2021
Physical storage location:: Deidentified data access can be requested by emailing [email protected] or [email protected] (Head of the Clinical Trials Unit and Data Access Committee Chair).
DOI:: 10.5287/bodleian:XmeOzdR8z

Language:: English
Keywords:: Cryptococcal Meningitis

Tamoxifen

R Code

Statistical analysis

SAS Code

Randomised controlled trial
Subjects:: Cryptococcus

Therapeutics

Meningitis

Clinical trials
Deposit date:: 2021-04-14

If you are the owner of this record, you can report an update to it here: Report update to this record